Literature DB >> 27546297

New psychoactive substances: driving greater complexity into the drug problem.

Michael Evans-Brown1, Roumen Sedefov1.   

Abstract

Keywords:  Early-warning systems; counterfeit medicines; fentanils; globalization; mass poisionings; new psychoactive substances; synthetic cannabinoids

Mesh：

Substances：

Year:  2016        PMID： 27546297     DOI： 10.1111/add.13528

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  5 in total

Review 1.  Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonists.

Authors:  Eun Yong Chung; Hye Jin Cha; Hyun Kyu Min; Jaesuk Yun
Journal:  Arch Pharm Res       Date:  2021-04-02       Impact factor: 4.946

2.  Return of the lysergamides. Part III: Analytical characterization of N6 -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD).

Authors:  Simon D Brandt; Pierce V Kavanagh; Folker Westphal; Simon P Elliott; Jason Wallach; Alexander Stratford; David E Nichols; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2017-05-10       Impact factor: 3.345

3.  Which individual, social and environmental influences shape key phases in the amphetamine type stimulant use trajectory? A systematic narrative review and thematic synthesis of the qualitative literature.

Authors:  Amy O'Donnell; Michelle Addison; Liam Spencer; Heike Zurhold; Moritz Rosenkranz; Ruth McGovern; Eilish Gilvarry; Marcus-Sebastian Martens; Uwe Verthein; Eileen Kaner
Journal:  Addiction       Date:  2018-10-12       Impact factor: 6.526

4.  New psychoactive substances in Eurasia: a qualitative study of people who use drugs and harm reduction services in six countries.

Authors:  Eliza Kurcevič; Rick Lines
Journal:  Harm Reduct J       Date:  2020-11-30

5.  Tracking Study on the Relapse and Aftercare Effect of Drug Patients Released From a Compulsory Isolated Detoxification Center.

Authors:  Nian Liu; Zekai Lu; Ying Xie
Journal:  Front Psychiatry       Date:  2022-01-17       Impact factor: 4.157
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.